Showing results (81-90 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|July 13, 2026
Anti-myeloma mechanisms of the selective NF-κB inhibitor QNZDana Cholujova, Zuzana Valuskova, Monika Burikova, et al.
Molecular Therapy. Oncology|August 30, 2026
StagX1, an isoquinolinone compound, selectively targets CES1-positive Ewing sarcoma cells as a potential therapeutic agentNenggang Zhang, Scott R Gilbertson, Feng Li, et al.
Molecular Therapy. Oncology|August 30, 2026
Erratum: Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signalingDiwakar Suresh, Akshatha N Srinivas, Bharathwaaj Gunaseelan, et al.
Molecular Therapy. Oncology|September 5, 2026
Ultrasound controllable and antigen-independent killing via cis-activating CAR T cellsLinshan Zhu, Jiaxin Cui, Chi-Wei Man, et al.
Molecular Therapy. Oncology|August 7, 2026
Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cellsRamon Alemany, Silvia Torres-Manjon, Laia Traveset, et al.
Molecular Therapy. Oncology|August 14, 2026
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapyBenjamin Vesin, Ingrid Fert, Sylvain Ciret, et al.
Molecular Therapy. Oncology|September 24, 2026
Preclinical evaluation of triple-mutated oncolytic herpes virus expressing fusion-type interleukin 12 for malignant melanomaMiwako Iwai, Akiko Higuchi Nonaka, Minoru Tanaka, et al.
Molecular Therapy. Oncology|April 7, 2025
SAP30, a novel autophagy regulatory gene in neuroblastomaAnup S Pathania, Anjana Murugan, Areem Zahid, et al.
Molecular Therapy. Oncology|April 16, 2025
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapyClément Riviere, Muna Aljieli, Marie-Noëlle Mévélec, et al.
Pageof 41